TecDAX

DGAP-News: CANCOM: New sustainability strategy sets climate neutrality target for 2027

Thursday, October 14, 2021 - 2:29pm

- New sustainability strategy sets targets for social and environmental sustainability.

Key Points: 
  • - New sustainability strategy sets targets for social and environmental sustainability.
  • The key ecological goal is to achieve climate neutrality for the entire CANCOM Group by 2027 at the latest.
  • In addition to climate neutrality, the sustainability strategy also includes investment targets for the training and further education of employees and a donation target for social and charitable commitments.
  • CANCOM's new sustainability website sustainability.cancom.com has been published in parallel with the sustainability strategy.

DGAP-News: Eckert & Ziegler Acquires 53,000 Square Feet Facility for Expansion of Contract Development and Manufacturing Services

Monday, October 11, 2021 - 12:06pm

The group plans to use the facility for the expansion of its contract development and manufacturing services that it provides, among others, for a variety of cancer therapeutics and radio diagnostics.

Key Points: 
  • The group plans to use the facility for the expansion of its contract development and manufacturing services that it provides, among others, for a variety of cancer therapeutics and radio diagnostics.
  • Due to its proximity to a thermal power station, the new site is expected to meet highest energy efficiencies.
  • The company also offers a broad range of services and products for the radiopharmaceutical industry, from early development work to contract manufacturing and distribution.
  • Eckert & Ziegler shares (ISIN DE0005659700) are listed in the TecDAX index of Deutsche Brse.

DGAP-News: Nantes University Hospital Doses First Patients with Eckert & Ziegler's Novel Ga-68 Imaging Agent PENTIXAFOR

Monday, September 27, 2021 - 2:19pm

The Centre Hospitalier Universitaire de Nantes (CHU), the French university hospital serving the greater Nantes/Saint-Nazaire metropolitan area, has started to dose first patients with PENTIXAFOR, an innovative imaging compound for the initial staging of cancer patients with symptomatic multiple myelomas.

Key Points: 
  • The Centre Hospitalier Universitaire de Nantes (CHU), the French university hospital serving the greater Nantes/Saint-Nazaire metropolitan area, has started to dose first patients with PENTIXAFOR, an innovative imaging compound for the initial staging of cancer patients with symptomatic multiple myelomas.
  • To investigate the potential of PENTIXAFOR the CHU will recruit, on its own account, up to 45 patients in a so-called investigator-initiated study (ISS).
  • Given the potential of PENTIXAFOR for improved patient stratification, academic groups like CHU have decided to move ahead on their own and to test PENTIXAFOR right away.
  • To speed up the PENTIXAFOR marketing authorization, Eckert & Ziegler closely cooperates with such initiatives and supports them where feasible.

DGAP-News: LPKF receives another order from the solar industry

Wednesday, September 15, 2021 - 4:13pm

Garbsen, 15 September 2021 - After the technology company LPKF Laser & Electronics AG received a major order from a leading global solar module manufacturer in July, LPKF now reports another order with a volume of almost EUR 10 million.

Key Points: 
  • Garbsen, 15 September 2021 - After the technology company LPKF Laser & Electronics AG received a major order from a leading global solar module manufacturer in July, LPKF now reports another order with a volume of almost EUR 10 million.
  • LPKF has been a leading supplier of highly specialized laser systems for structuring thin-film solar modules for 14 years.
  • Christian Witt, CFO of LPKF, says: "With these two major orders we have strengthened our strong position in the solar market.
  • With the new order, the order backlog in the Solar segment exceeds EUR 40 million.

DGAP-News: Managing Board of SMA Solar Technology AG adjusts forecast for the current fiscal year

Monday, September 6, 2021 - 5:02pm

Niestetal, September 6, 2021 - The Managing Board of SMA Solar Technology AG (SMA/FWB: S92) is adjusting its sales and earnings forecast for the current fiscal year.

Key Points: 
  • Niestetal, September 6, 2021 - The Managing Board of SMA Solar Technology AG (SMA/FWB: S92) is adjusting its sales and earnings forecast for the current fiscal year.
  • For 2021, the SMA Managing Board expects sales between 980 million and 1030 million (previously: 1075 million to 1175 million) and EBITDA between 50 million and 65 million (previously: 75 million and 95 million).
  • SMA inverters with a total output of more than 100 gigawatts have been installed in more than 190 countries worldwide.
  • Since 2008, the Group's parent company, SMA Solar Technology AG, has been listed on the Prime Standard of the Frankfurt Stock Exchange (S92) and is listed in the TecDAX index.

Sartorius To Join The DAX Blue Chip Index

Saturday, September 4, 2021 - 8:00am

GTTINGEN, Germany, Sept. 4, 2021 /PRNewswire/ -- The life science group Sartorius will be admitted to the German DAX blue chip index.

Key Points: 
  • GTTINGEN, Germany, Sept. 4, 2021 /PRNewswire/ -- The life science group Sartorius will be admitted to the German DAX blue chip index.
  • In addition, Sartorius preference shares will continue to be listed on the TecDAX, the leading index of the German technology stocks.
  • Membership in the DAX shows the increasing importance of the biotech and life science sectors and puts Sartorius even more in the public eye.
  • Thus, approximately one-third of Sartorius' total market capitalization will be taken into account for determining membership in the DAX.

DGAP-News: Eckert & Ziegler Starts Technetium-99 Delivery in Brazil

Thursday, August 26, 2021 - 10:02am

Eckert & Ziegler (ISIN DE0005659700, TecDAX), has started the delivery of Technetium-99 generators in Brazil.

Key Points: 
  • Eckert & Ziegler (ISIN DE0005659700, TecDAX), has started the delivery of Technetium-99 generators in Brazil.
  • The subsidiary Eckert & Ziegler Brasil Comercial Ltda.
  • Eckert & Ziegler already supplies around 500 hospitals and clinics in this country with medical products and radioisotopes and now hopes to tap into the generator market.
  • Eckert & Ziegler Strahlen- und Medizintechnik AG with more than 800 employees is a leading specialist for isotope-related components in nuclear medicine and radiation therapy.

DGAP-News: SMA Solar Technology AG Significantly Improves Earnings in the First Half of 2021

Thursday, August 12, 2021 - 7:03am

Stockpiling supports SMA's delivery capacity for the expected positive business performance to come in the second half of 2021.

Key Points: 
  • Stockpiling supports SMA's delivery capacity for the expected positive business performance to come in the second half of 2021.
  • "Compared with the first six months of the previous year, we have increased our earnings (EBITDA) by around 60% in the first half of 2021.
  • SMA inverters with a total output of more than 100 gigawatts have been installed in more than 190 countries worldwide.
  • Since 2008, the Group's parent company, SMA Solar Technology AG, has been listed on the Prime Standard of the Frankfurt Stock Exchange (S92) and is listed in the TecDAX index.

DGAP-News: CANCOM: Outstanding growth rates in the second quarter and first half of 2021

Thursday, August 12, 2021 - 7:03am

- CANCOM Group increases revenue by 18.6 percent in the second quarter of 2021 and by 12.8 percent in the first half of 2021.

Key Points: 
  • - CANCOM Group increases revenue by 18.6 percent in the second quarter of 2021 and by 12.8 percent in the first half of 2021.
  • This leads to growth rates of 37.2 percent for EBITDA and 96.4 percent for EBIT for the first half of the year.
  • Munich, Germany, 12 August 2021 - The CANCOM Group achieved outstandingly high growth rates in revenue and earnings in the second quarter of the financial year 2021.
  • The EBITDA margin for the CANCOM Group in the second quarter was thus 9.4 percent (prior year: 7.0 percent).

DGAP-News: ​​​​​​​Eckert & Ziegler with Strong First Half of 2021

Thursday, August 12, 2021 - 7:02am

Eckert & Ziegler Strahlen- und Medizintechnik AG (ISIN DE0005659700, TecDAX), achieved a new record result in the first half of 2021 with a net profit of 22.3 million or 1.08 per share.

Key Points: 
  • Eckert & Ziegler Strahlen- und Medizintechnik AG (ISIN DE0005659700, TecDAX), achieved a new record result in the first half of 2021 with a net profit of 22.3 million or 1.08 per share.
  • Revenues of the Group amounted to 89.5 million and were thus 7% above the previous year's level.
  • With around 22 million, the Eckert & Ziegler Group achieved earnings in the first half of 2021 that exceeded original expectations.
  • Eckert & Ziegler shares (ISIN DE0005659700) are listed in the TecDAX index of Deutsche Brse.